Neonatal sepsis in rural India: Timing, microbiology and antibiotic resistance in a population-based prospective study in the community setting

Journal of Perinatology

Volumn 37, Issue 8, 2017, Pages 911-921

  Panigrahi, P ^a   Chandel, D S ^a   Hansen, N I ^b   Sharma, N ^c   Kandefer, S ^b   Parida, S ^d   Satpathy, R ^e   Pradhan, L ^f   Mohapatra, A ^g   Mohapatra, S S ^e   Misra, P R ^g   Banaji, N ^h   Johnson, J A ⁱ   Morris, J G ⁱ   Gewolb, I H ^j   Chaudhry, R ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b RTI INTERNATIONAL   (United States)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d SCB MEDICAL COLLEGE   (India)

^e Asian Institute of Public Health   (India)

^f Capital Hospital   (India)

^g Asian Institute of Public Health   (India)

^h INDIRA GANDHI MEDICAL COLLEGE   (India)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^j Claire Dart Stroke Center Sparrow Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFALEXIN; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFIXIME; CEFMETAZOLE; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLOXACILLIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

AEROMONAS HYDROPHILA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CANDIDA; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; FLAVOBACTERIUM; FLAVOBACTERIUM ORYZIHABITANS; HUMAN; INCIDENCE; INDIA; INFANT; KLEBSIELLA; KLEBSIELLA ORNITHINOLYTICA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SEPSIS; PASTEURELLA PNEUMOTROPICA; POPULATION RESEARCH; PROSPECTIVE STUDY; PROTEUS VULGARIS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA; RURAL AREA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; CLASSIFICATION; DISEASE MANAGEMENT; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; DISEASE MANAGEMENT; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INCIDENCE; INDIA; INFANT, NEWBORN; KLEBSIELLA; MALE; NEONATAL SEPSIS; STAPHYLOCOCCUS AUREUS;

EID: 85028337956     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2017.67     Document Type: Article

References (16)

1. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015; 385: 430-440.
2. Waters D, Jawad I, Ahmad A, Lukšic I, Nair H, Zgaga L et al. Aetiology of community-acquired neonatal sepsis in low and middle income countries. J Glob Health 2011; 1: 154-170.
3. Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14: 731-741.
4. Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med 2016; 13(3): e1001974.
5. African Neonatal Sepsis Trial (AFRINEST) group, Tshefu A, Lokangaka A, Ngaima S, Engmann C, Esamai F et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet 2015; 385: 1767-1776.
6. Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J 2009; 28: S10-S18.
7. The WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J 1999; 18(suppl 10): S17-S22.
8. National Committee for Clinical Laboratory Standards (NCCLS). Development of in vitro susceptibility testing criteria and quality control parameters: approved guideline [M23-A2]. 2nd edn. NCCLS: Wayne, PA, 2001.
9. The Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 2008; 371: 135-142.
10. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospitalacquired neonatal infections in developing countries. Lancet 2005; 365: 1175-1188.
11. Hamer DH, Darmstadt GL, Carlin JB, Zaidi AK, Yeboah-Antwi K, Saha SK et al. Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J 2015; 34(1): e1-e8.
12. Chandel DS, Johnson JA, Chaudhry R, Sharma N, Shinkre N, Parida S et al. Extended-spectrum β-lactamase producing gram-negative bacteria causing neonatal sepsis in India in rural and urban settings. J Med Microbiol 2011; 60(4): 500-507.
13. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL et al. Return of chloroquine antimalarial efficacy in Malawi. N Eng J Med 2006; 355: 1959-1966.
14. Stokes DJ, Kelly AF, Gould SW, Cassar CA, Fielder MD. The withdrawal of antimicrobial treatment as a mechanism for defeating resistant microorganisms. FEMS Immunol Med Microbiol 2008; 53: 300-305.
15. Islam MS, Baqui AH, Zaidi AK, Bhutta ZA, Panigrahi P, Bose A et al. Infection surveillance protocol for a multicountry population-based study in south Asia to determine the incidence, etiology and risk factors for infections among young infants of 0 to 59 days old. Pediatr Infect Dis J 2016; 35(Suppl 1): S9-S15.
16. Satpathy R, Nanda P, Nanda NC, Bal HB, Mohanty R, Mishra A et al. Challenges in Implementation of the ANISA protocol at the Odisha site in India. Pediatr Infect Dis J 2016; 35(Suppl 1): S74-S78.